This inventor holds 1 USPTO granted patent. Top assignee: Adiutide Pharmaceuticals Gmbh. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Marion Jürk: Innovator in Immunostimulatory Oligonucleotides
Introduction
Marion Jürk is a notable inventor based in Dormagen, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotide analogs with enhanced immunostimulatory activity. Her work has implications for pharmaceutical compositions and therapeutic methods.
Latest Patents
Marion Jürk holds a patent for "Phosphate-modified oligonucleotide analogs with enhanced immunostimulatory activity." This invention relates to oligonucleotides that include at least one backbone modification and a pyrimidine-purine dinucleotide. The patent also covers pharmaceutical compositions and methods of use thereof. She has 1 patent to her name.
Career Highlights
Marion Jürk is currently employed at Adiutide Pharmaceuticals GmbH, where she continues to advance her research in oligonucleotide technology. Her innovative work is paving the way for new therapeutic approaches in immunology.
Collaborations
Marion collaborates with Eugen Uhlmann, contributing to the development of cutting-edge biopharmaceuticals.
Conclusion
Marion Jürk's contributions to the field of biotechnology, particularly through her patented innovations, highlight her role as a leading inventor in the development of immunostimulatory oligonucleotides. Her work at Adiutide Pharmaceuticals GmbH continues to influence the future of pharmaceutical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile